Efficacy and Safety Clinical Trial of Intranasal AST-726 for the Prevention of Migraine

Clinical trial NCT00285402 · UNKNOWN

Trial details

NCT number: NCT00285402
Sponsor: Ariston Pharmaceuticals, Inc.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Migraine Migraine Headache Migraine Disorders Migraine With Aura Migraine Without Aura

Start date: 2007-05-01
Primary completion: 2008-06-01
Enrollment: 198

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.